Introduction and Objective: Transplantation of free islets is limited by the need for systemic immune suppression. To protect transplanted cells from the autoimmune response and avoid the negative effects of systemic immune suppression, which can include damage to remaining and transplanted beta cells, we are developing physical immune-protective hydrogels. We demonstrated good survival and function […]
Read MoreAuthor: sugaradmin
1347-P: Glycated Hemoglobin (A1C) Testing—Ineffectiveness Due to Hematological Alterations
Introduction and Objective: Glycated hemoglobin (A1C) is widely used in the screening and follow-up of patients with diabetes mellitus (DM), making its accuracy critical for patient care. However, A1C results can be influenced by various factors, including alterations in blood cell counts. This study aimed to evaluate the correlation between hematological abnormalities and inaccuracies in […]
Read More36-PUB: Developing an Evidence-Based Care Pathway for Transgender Youth with Obesity—Integration of Patient and Caregiver Perspectives
Introduction and Objective: Pediatric obesity rates continue to rise, and with them, comorbidities such as Type 2 diabetes. Transgender youth may be more susceptible to these conditions due to gender- and weight-based stigmatization, increased BMI from gender-affirming therapies, and maladaptive weight management behaviors. Furthermore, current pediatric weight management uses a “one size fits all” approach […]
Read More1288-P: Waist–to–Body-Mass-Index Ratio Predicts Cardiovascular Events in Patients with Coronary Artery Disease beyond the Metabolic Syndrome
Introduction and Objective: The waist circumference-to-body-mass-ratio (W/BMI-Ratio) has attracted interest as a predictor of cardiovascular risk. Its power to predict cardiovascular events in patients with established coronary artery disease (CAD) is not known and is addressed in the present study.Methods: We prospectively recorded cardiovascular events in 1329 patients with angiographically verified coronary artery disease. The […]
Read More259-OR: Evaluating Diabetic Foot Ulcer Recognition Algorithms for Patients of Color
Introduction and Objective: Computer vision offers an opportunity to automatically analyze foot images to segment diabetic foot ulcers (DFU) and determine clinically relevant characteristics. Although diabetic foot complications take a disproportionate toll on communities of color, these communities are underrepresented in dermatologic image datasets, which may propagate health disparities. Are current state-of-the-art foot ulcer recognition […]
Read More1287-P: Type 2 Diabetes and Albuminuria as Predictors of Major Cardiovascular Events in Patients with Established Cardiovascular Disease
Introduction and Objective: This study aims to investigate the single and joint effects of T2DM and albuminuria on major cardiovascular events (MACE) in patients with established cardiovascular disease (CVD).Methods: We prospectively investigated 854 patients with CVD (743 with coronary artery disease and 111 with peripheral artery disease) over 9.3±4.5 years. Albuminuria was defined as urine […]
Read More2135-LB: The Study of Abnormal SLAMF Molecular Expression on Immune Cells in Type 1 Diabetic Patients and Associated Mechanism
Introduction and Objective: At present, the pathogenesis of T1DM is not completely clear, and more and more studies have shown that CD8+T cells play an important role in the pathogenesis of type 1 diabetes. It has been reported that the signaling lymphocyte activated molecular family (SLAMF) is abnormally expressed in various immune disorders and affects […]
Read More1286-P: The Visceral Adiposity Index Predicts the Development of Type 2 Diabetes Mellitus in Patients with Established Coronary Artery Disease
Introduction and Objective: The visceral adiposity Index (VAI) is a reliable biomarker of insulin resistance and is associated with the metabolic syndrome as well as with type 2 diabetes (T2DM). Its power to predict the development of T2DM in patients with established coronary artery disease (CAD) is unclear and is addressed in the presence study.Methods: […]
Read More547-P: Harnessing Continuing Education to Identify Drivers of Obesity Medication Use among Primary Care Providers
Introduction and Objective: Obesity is a risk factor for type 2 diabetes (T2D), with weight loss linked to improved glycemic control and reduced disease burden. Obesity medications (OMs) are available to reduce weight and risk associated with T2D, yet misinformation and lack of confidence hinder their use.Methods: In September 2024, Vindico provided the 12th Annual […]
Read More1285-P: The Triglyceride–Glucose Index and Type 2 Diabetes Are Mutually Independent Predictors of Major Cardiovascular Events in Patients with Established Cardiovascular Disease
Introduction and Objective: The triglyceride-glucose index (TyG) is a validated biomarker of insulin resistance. Its power to predict major cardiovascular events (MACE) in patients with established cardiovascular disease is unclear and is addressed in the present study.Methods: We enrolled 1790 consecutive patients, 1481 with angiographically proven CAD and 309 with sonographically proven PAD. Prospectively, MACE […]
Read More